Skip to main content
. 2026 Sep 8;18(18):2906. doi: 10.3390/cancers18182906
PCNSL Primary central nervous system lymphoma
MRI Magnetic resonance imaging
PFS Progression-free survival
OS Overall survival
HD-MTX High-dose methotrexate
WBRT Whole-brain radiotherapy
IELSG International Extranodal Lymphoma Study Group
MSKCC Memorial Sloan-Kettering Cancer Center
CSF Cerebrospinal fluid
DLBCL Diffuse large B-cell lymphoma
KPS Karnofsky Performance Status
ECOG Eastern Cooperative Oncology Group
LDH Lactate dehydrogenase
HR Hazard ratio
CI Confidence interval
CR Complete response
PR Partial response
SD Stable disease
PD Progressive disease
ORR Overall response rate
RT Radiotherapy